|
|
| | 1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)- Basic information |
| Product Name: | 1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)- | | Synonyms: | 1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)-;benzyl (3S,4R)-3-ethyl-4-((5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-yl)glycyl)pyrrolidine-1-carboxylate;Upadacitinib Impurity 53;Upadacitinib Impurity 25(Dihydrochloride);Upatinib impurity 50;8-((3S,4R)-4-ethylpyrrolidin-3-yl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine dihydrochloride;RMA-799;3-ethyl-8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine | | CAS: | 2270173-63-0 | | MF: | C29H31N5O5S | | MW: | 561.65 | | EINECS: | | | Product Categories: | | | Mol File: | 2270173-63-0.mol | ![1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)- Structure](CAS/20210111/GIF/2270173-63-0.gif) |
| | 1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)- Chemical Properties |
| Boiling point | 766.2±70.0 °C(Predicted) | | density | 1.36±0.1 g/cm3(Predicted) | | pka | 3.13±0.30(Predicted) |
| | 1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)- Usage And Synthesis |
| | 1-Pyrrolidinecarboxylic acid, 3-ethyl-4-[2-[[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-, phenylmethyl ester, (3S,4R)- Preparation Products And Raw materials |
|